NEWARK, Del.--(BUSINESS WIRE)--iBio, Inc. (OTCBB: IBPM) announces the appointment of distinguished infectious disease and vaccine manufacturing and licensing expert Arthur Y. Elliott, PhD, to its board of directors. The addition brings to seven the number of diverse professionals who will help guide the biotech company as clinical trials and other commercialization initiatives utilizing iBio’s disruptive plant-based iBioLaunch™ technology platform proceed.
